Correlogic Systems, Inc. Product Pipeline Analysis

Published by: Global Markets Direct

Published: Jan. 1, 2009 - 23 Pages

Table of Contents

1 Table of Contents

1.1 List Of Tables

1.2 List of Figures

2 Company Overview

2.1 Key Information

2.2 Industry Outlook - In Vitro Diagnostics

3 Correlogic Systems, Inc. Pipeline Products

3.1 Correlogic Systems, Inc. Product Pipeline Analysis

3.1.1 Correlogic Systems, Inc. Pipeline Products By Equipment Type

3.1.2 Correlogic Systems, Inc. Pipeline Products By Development Stage

3.1.3 Correlogic Systems, Inc. Pipeline Products By Therapy Area

3.1.4 Correlogic Systems, Inc. Pipeline Products By Clinical Trials

3.1.5 Correlogic Systems, Inc. Pipeline Products By News Summary

3.2 OvaCheck

3.2.1 Product Status

3.2.2 Product Description

3.2.3 Product Milestone

3.3 MammoCheck

3.3.1 Product Status

3.3.2 Product Description

3.3.3 Product Milestone

3.4 ProstaCheck

3.4.1 Product Status

3.4.2 Product Description

3.4.3 Product Milestone

3.4.4 Clinical Trials

3.5 Blood test(colorectal cancer)

3.5.1 Product Status

3.5.2 Product Description

3.5.3 Product Milestone

3.6 Blood test (Wegners disease)

3.6.1 Product Status

3.6.2 Product Description

3.6.3 Product Milestone

3.7 Experimental drug toxicity testing

3.7.1 Product Status

3.7.2 Product Description

3.7.3 Product Milestone

4 Recent Developments

4.1 Product News

4.1.1 Feb 19, 2008: Quest Diagnostics To Develop Blood Test To Aid In The Detection Of Colorectal Cancer

4.1.2 May 15, 2005: A Serum Pattern Predictive of Breast Cancer

4.1.3 May 03, 2005: Development of Correlogic’s Prostate Cancer Blood Tests to Move Forward through Research Collaboration with the Uniformed Services University of the Health Sciences and the Henry M. Jackson Foundation for the Advancement of Military Medicine

4.1.4 Mar 03, 2005: A Serum Proteomic Approach to Gauging the State of Remission in Wegener’s Granulomatosis

4.1.5 Jun 21, 2004: Correlogic Systems’ Ovarian Cancer Blood Test to Advance through North Shore-LIJ Research Institute Research Collaboration

4.1.6 Mar 03, 2004: Toxicoproteomics: Serum Proteomic Pattern Diagnostics For Early Detection Of Drug Induced Cardiac Toxicities And Cardioprotection

4.1.7 Nov 06, 2002: Correlogic Systems Licenses Ovarian Cancer Diagnostic Test To Quest Diagnostics and LabCorp

5 Appendix

5.1 Methodology

5.1.1 Coverage

5.1.2 Secondary Research

5.1.3 Primary Research

5.1.4 Expert Panel Validation

5.2 Contact Us

5.3 About Global Markets Direct

5.4 Disclaimer

1.1 List of Tables

Table 1: Correlogic Systems, Inc.,Key Facts

Table 2: Correlogic Systems, Inc. Pipeline Products by Equipment Type

Table 3: Correlogic Systems, Inc. Pipeline Products By Development Stage

Table 4: Correlogic Systems, Inc. Pipeline Products By Therapy Area

Table 5: Correlogic Systems, Inc. Pipeline Products By Clinical Trials

Table 6: Correlogic Systems, Inc. Pipeline Products By News Summaries

Table 7: OvaCheck, Product Status

Table 8: OvaCheck, Product Description

Table 9: MammoCheck, Product Status

Table 10: MammoCheck, Product Description

Table 11: ProstaCheck, Product Status

Table 12: ProstaCheck, Product Description

Table 13: ProstaCheckClinical Trials 1

Table 14: Blood test(colorectal cancer), Product Status

Table 15: Blood test(colorectal cancer), Product Description

Table 16: Blood test (Wegners disease), Product Status

Table 17: Blood test (Wegners disease), Product Description

Table 18: Experimental drug toxicity testing, Product Status

Table 19: Experimental drug toxicity testing, Product Description

1.2 List of Figures

Figure 1: Correlogic Systems, Inc. Pipeline Products By News Summary

Figure 2: Global Markets Direct Methodology

Abstract

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
• Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
• Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.